Article Details

Merck to Seek FDA EUA for COVID-19 Pill after Positive Phase III Data

Retrieved on: 2021-10-01 13:57:07

Tags for this article:

Click the tags to see associated articles and topics

Merck to Seek FDA EUA for COVID-19 Pill after Positive Phase III Data. View article details on hiswai:

Excerpt

An analysis of the approximately 40% of patients with available viral sequencing data found molnupiravir to have shown consistent efficacy across the Gamma, ...

Article found on: www.genengnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up